Moderated Poster
SCREEN 1
Chairs: Rebeca Lorca, Pilar Mazón
19 - CLINICAL, BLOOD BIOMARKERS AND IMAGING AS PREDECTIVE FACTORS OF CARDIOTOXICY IN LYMPHOMA PATIENTS RECEIVING ANTRHACILINES IN FRONT LINE TREATMENT: A RETROSPECTIVE STUDY
Alberto Lopez-Garcia
46 - A Study To Assess The Ability Of The HFA-ICOS Risk Stratification Tool To Predict Cancer Therapy-Related Cardiac Dysfunction For Patients Receiving Anthracycline Chemotherapy.
Clare Bannister Bannister
31 - Impact Of AI-Based Automated Analysis For Cardiotoxicity Surveillance In Oncology Patients
Benjamin Matthew Dowsing
SCREEN 2
Chairs: Anju Nohria, Giselle Melendez
49 - Contemporary One-Year Outcomes In Patients With Fulminant Vs. Non-Fulminant Immune Checkpoint Inhibitor-Induced Myocarditis
Anju Nohria
52 - Prognostic Indicators After Anti-Inflammatory Treatment In Cancer Patients With Pericardial Effusion
Hyukjin Park
55 - Cardiovascular And Other Comorbidities In Colorectal Cancer Patients In Central-Eastern Europe
Bence Prohászka
SCREEN 3
Chairs: Mariana Mirabel, Negareh Mousavi
29 - Mitochondrial Dynamics And Myocardial Metabolism Alterations During Anthracycline-Cardiotoxicity
Anabel Díaz-Guerra
32 - Characterization Of Senescence In Human Cardiac Fibroblasts
Ambra Costa
40 - TIM-3 Is Associated With Cardiac Remodeling In Patients With A Myocardial Infarction.
Laura Yousif
SCREEN 4
Chairs: Anthony Yu, Ana Barac
111 - Can Atrial Strain Be Used To Help Stratify Patients Who Are Referred For BTK Inhibitors?
Jesús Saldaña García
47 - RAPID-CARDIOTOX: A Targeted CMR Protocol With Fully-Automated Analysis Increases Feasibility Of Cardiotoxicity Imaging Surveillance Using CMR
Jessica Artico
101 - Cardiovascular Disease In Men With Breast Cancer: Incidence, Risk Factors, And Mortality
Anjali Chauhan